-transparent.png){kind=logo}
We determined the expression of the multidrug resistance-associated protein (MRP), a new putative transmembrane drug transporter, in peripheral blood cells from healthy volunteers as well as from 60 patients with acute or chronic leukemia, using an RNase protection assay. MRP appeared to be ubiquitously expressed at low levels in all nonmalignant hemopoietic cell types, reflecting its basal constitutive expression. In acute myelocytic leukemia (AML) (n = 16), one of nine untreated patients and two of seven patients with prior chemotherapy showed significant hyperexpression of MRP. In chronic lymphocytic leukemia (CLL) (n = 21), either treated (n = 8) or untreated (n = 13), a high percentage (15 of 21: 71% had relatively high expression levels of the MRP gene. In contrast, low MRP expression levels were detected in acute lymphocytic leukemia (n = 14), and in chronic myelocytic leukemia (n = 9). DNA analysis by Southern blotting did not reveal amplification of the MRP gene in the leukemia samples, including those with elevated MRP mRNA levels. We conclude that relatively high expression of MRP is occasionally observed in AML and at high frequency in CLL, irrespective of treatment, probably due to transcriptional activation and/or increased mRNA stability.
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
December 1994,
Leukemia,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
January 1997,
Anti-cancer drugs,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
October 1995,
Leukemia,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
January 2002,
Leukemia & lymphoma,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
February 1998,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
September 2000,
Journal of neuro-oncology,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
August 1995,
Cancer letters,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
January 1997,
British journal of cancer,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
December 1996,
International journal of cancer,
H Burger, and
K Nooter, and
G J Zaman, and
P Sonneveld, and
K E van Wingerden, and
R G Oostrum, and
G Stoter
June 1996,
European journal of cancer (Oxford, England : 1990),
